TYLENOL PM
- Product NDC
- 50580-833
- 11-digit product format
- 505800833
- Labeler code
- 50580
- Product ID
- 50580-833_5def488c-5857-81d7-e063-6294a90ac270
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-25
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 1000; 50 mg/30mL; mg/30mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 50580-833-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 50580-833-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 50580-833-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 50580-833-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 50580-833-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 50580-833-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 50580-833-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 50580-833-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 50580-833-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 50580-833-01 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYLENOL PM
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 1000 mg/30mL |
| DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44e8a92a-748b-4dc3-ae8d-176a350ac83d | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-833-01 | ML - Milliliter | 50580-833 | 4eb50548-bfd6-4ca0-8b96-8e53a76d98be | 1 | 2018-10-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen, Aspirin, and Caffeine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Bi-Mart | 40cd1a7a-e941-4503-8fe4-e939bd0d9d72 | 2025-07-02 | Warnings | M013 |
| Maximum Strength Cough and Chest Congestion and Nighttime Severe Cold and Flu Combo pack | DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE | Genexa Inc. | 18835205-a9e3-15c2-e063-6394a90a8107 | 2025-07-02 | Warnings | M013 |
| FeverAll | ACETAMINOPHEN | Sun Pharmaceutical Industries, Inc. | 8970b91b-5f3c-4764-9e23-25dcb398d0a7 | 2025-07-02 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | Meijer Distribution Inc | 11c9712d-c3b2-49cd-9c2b-0f57190c954e | 2025-07-02 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN | United Natural Foods, Inc. dba UNFI | 979973c1-661a-4384-8b92-fd901ebde558 | 2025-07-01 | Warnings | M013 |
| Pain and Fever Childrens | ACETAMINOPHEN | CVS Pharmacy | f6bbce1c-9790-4ca4-847f-579c594ffe0b | 2025-07-01 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | WALGREENS | 07d2e322-2465-79e5-e063-6294a90a5ea4 | 2025-06-30 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | DISCOUNT DRUG MART | 66c0cf26-357b-4722-9100-3b86d507a8cd | 2025-06-30 | Warnings | M013 |
| ALLERGY | DIPHENHYDRAMINE HYDROCHLORIDE | Kroger Company | bc019c9e-8fac-5fd3-e053-2a95a90a7ccd | 2025-06-25 | Warnings | M013 |
| ACETAMINOPHEN Extra Strength | ACETAMINOPHEN | TIME CAP LABS INC | fd24d0e0-4f36-42d3-9149-2fb957690305 | 2025-06-25 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | ATLANTIC BIOLOGICALS CORP. | 024c5054-959f-4ea5-a71f-c0e16cc4b90c | 2025-06-24 | Warnings | M013 |
| CHILDRENS ACETAMINOPHEN | CHILDRENS ACETAMINOPHEN ORAL | AARNA USA INC. | 38070d15-2678-4e59-e063-6294a90ab690 | 2025-06-20 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Morning Star OTC | 8502ea21-937d-4b33-a3e0-ffab5dc38cd8 | 2025-06-19 | Warnings | M013 |
| Tylenol PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Morning Star OTC | 6cd07a01-7034-4994-bbd3-bedcdf7d5b83 | 2025-06-19 | Warnings | M013 |
| DRX CHOICE Tension Headache | ACETAMINOPHEN, CAFFEINE | Raritan Pharmaceuticals Inc. | 8a5cb38b-669d-4177-b33b-d73c7ef48d18 | 2025-06-13 | Warnings | M013 |
| good sense childrens pain and fever | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 3777f4fb-d279-199d-e063-6394a90acf36 | 2025-06-13 | Warnings | M013 |
| Aspirina Cafeina | ASPIRIN,CAFFEINE | Bayer HealthCare LLC. | 2e709acc-325a-baca-e063-6394a90a24be | 2025-06-12 | Warnings | M013 |
| Aspirin | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 696f55b1-536c-40c4-91f7-b572c39220db | 2025-06-11 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | CVS Pharmacy, Inc. | 6dea9e11-ff99-63c7-e053-2a91aa0a5b54 | 2025-06-10 | Warnings | M013 |
| Children Acetaminophen Oral Solution | ACETAMINOPHEN | MAJOR PHARMACEUTICALS | cfca5147-f390-40bd-8f13-c5b3b8d1c5b0 | 2025-06-09 | Warnings | M013 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-833-01 | 50580083301 | 240 mL in 1 BOTTLE (50580-833-01) | 240 ml | 2018-06-25 | 0000-00-00 | No | No | Current |